Skip to content

Sichenzia Ross Ference LLP Represents EF Hutton in $8.4 Million Simultaneous Registered Direct Offering and Private Placement of Securities of Nemaura Medical, Inc.

Press Release – New York, NY – January 2023 – Sichenzia Ross Ference LLP announced today that it represented EF Hutton, division of Benchmark Investments LLC, acting as the exclusive placement agent, in a registered direct and private placement of the securities of Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing…

Read More

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8 Million Underwritten Public Offering of BiondVax Pharmaceuticals Ltd.

Press Release – New York, NY – December 21, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book running manager in the $8 Million underwritten public offering of BiondVax Pharmaceuticals, a biotechnology company which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products. The offering consisted of 1,600,000…

Read More

Sichenzia Ross Ference LLP Represents Hudson Acquisition I Corp. in $68.4 Million Initial Public Offering

Press Release – New York, NY –  October 21, 2021 – Sichenzia Ross Ference LLP announced today that it represented Hudson Acquisition I Corp. (NASDAQ: HUDA) in its initial public offering.  HUDA is a Special Purpose Acquisition Company.  The Hudson Management team is led by CEO Jiang Hui, a seasoned financial professional with deep experiences in banking…

Read More
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.